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Introduction
The growth of collateral arteries (arteriogenesis) following the
stenosis or occlusion of a major blood vessel is an important pro-
tective mechanism in patients with vascular occlusive diseases.
Arteriogenesis is driven by the pressure gradient between pre- and
post-stenotic perfusion territories, resulting in an increased flow
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Abstract
During collateral artery growth, monocytes adhere to the endothelium and secrete cytokines from the perivascular space promoting
arteriogenesis. Recently, the endothelial glycocalyx has been shown to modulate leucocyte infiltration in atherogenic regions. The role
of this endothelial surface coating in arteriogenesis, however, has not been investigated so far. We now report that local plasma lev-
els of hyaluronic acid are specifically increased in collateral arterial blood of coronary artery disease patients and hypothesized that
components of the endothelial glycocalyx are shed during arteriogenesis, resulting in decreased glycocalyx dimensions and an
increased leucocyte extravasation. In a rabbit model of femoral artery ligation, electron microscopy revealed a decrease in glycocalyx
dimensions in collateral arteries compared with quiescent anastomoses (67.5  47.2 nm versus 101.0  11.3 nm; P  0.001). This
decrease was correlated with a higher number of perivascular macrophages around collateral arteries. The additional glycocalyx per-
turbation by local hyaluronidase infusion almost completely removed the endothelial surface layer and temporarily stimulated leuco-
cyte accumulation in the perivascular space. However, complete perturbation of the glycocalyx by hyaluronidase infusion resulted in 
a significant attenuation of collateral artery growth assessed by microsphere-based perfusion measurements (ml/min/100 mmHg:
hyaluronidase: 27.5  3.5; Controls: 47.1  3.83; P  0.001) and a lower percentage of actively proliferating vascular smooth muscle
cells. A decreased expression of the shear-stress regulated pro-arteriogenic genes eNOS and TGF-1 suggests an impaired mechan-
otransduction as the underlying mechanisms. For the first time, we describe the role of the endothelial glycocalyx in collateral artery
growth. Although complete abrogation led to attenuated arteriogenesis, shedding of glycocalyx components is observed during col-
lateral artery growth.
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via small arterial and arteriolar anastomoses. Triggered by this
increase in shear stress, distinct transcription factors, cytokines
and adhesion molecules are expressed by the collateral endothe-
lial cells and result in the adhesion and subsequent infiltration of
circulating cells [1], especially leucocytes. Among these cell pop-
ulations, infiltrating monocytes have been shown to play a major
role as mediators of arterial remodelling and eventually an
enlargement of the collateral artery.
Recently, the endothelial glycocalyx has been implicated in the
mediation of leucocyte adhesion in atherosclerotic disease. This
network of negatively charged proteoglycans, glycoproteins and
glycosaminoglycans lines the luminal wall of all blood vessels.
During atherogenesis, a disturbance of the glycocalix by turbulent
shear stress patterns results in a decrease of the glycocalyx width,
allowing the approximation of circulating cells to the endothelium
and the adhesion and infiltration of monocytes, resulting in 
atherosclerotic plaque formation [2]. In addition, the endothelial
glycocalyx plays an important role in the shear stress sensing,
mechanotransduction and NO-mediated vasodilation. Both leuco-
cyte infiltration as well as shear stress sensing are of eminent
importance for the growth of collateral arteries [3, 4], but the struc-
tural morphology of the glycocalyx in growing collateral arteries, its
reaction upon collateral vessel recruitment or its functional impor-
tance for arteriogenesis have not yet been investigated.
In this study, we aimed to screen for indirect parameters of
local glycocalyx alterations in collateral arteries of coronary artery
disease patients by measuring local plasma levels of glycocalyx
components in the collateral circulation. We further investigated
glycocalyx morphology and effects of glycocalyx modulation on
arteriogenesis in a rabbit model of collateral artery growth.
Experimental procedures
Patient study
Patient selection. This study was approved by the institutional medical
ethics committee. After giving informed consent, 40 Caucasian patients
scheduled for percutaneous coronary intervention (PCI) of a high-grade
stenosis (n  24) or a total coronary occlusion (n  16) were included.
Exclusion criteria were previous myocardial infarction in the area of 
collateralization, previous cardiac surgery, severely depressed left ven-
tricular function, diabetes mellitus, neoplastic disease and signs of
inflammatory illness.
Collateral flow index (CFI). Forty patients with stable coronary artery
disease underwent coronary angiography following intracoronary injection
of 0.1 mg nitroglycerine. Quantitative coronary angiography (Medis,
Leiden, The Netherlands) was performed to determine the percentage
stenosis using perpendicular images.
A 0.014 pressure guide wire (BrightWire, Volcano, Rancho Cordova,
CA) was used for intracoronary pressure measurements. During a 1-min.
balloon inflation, the pressure distal to the coronary occlusion (wedge
pressure, Pw) as well as aortic (Pao) pressure were determined. CFI was
calculated as (Pw–5 mmHg)/(Pao–5 mmHg) as described previously [5].
Intracoronary blood plasma collection. For intracoronary blood sam-
pling, a 7F (inner diameter 0.051) proximal embolic protection device
(Proxis®- catheter, St. Jude Medical, St. Paul, MN) was advanced through
the guiding catheter and into the treated coronary artery which received
collateral blood. Inflating a low-pressure (0.67 atm) balloon at the end of
the catheter temporarily stops antegrade blood flow in the artery.
Subsequently, gentle suction was applied manually to the proximal end of
the catheter. The first 3 ml aspirated were discarded to prevent contamina-
tion with contrast medium. Approximately 10–15 ml blood were then aspi-
rated within 1–2 min. from the retrogradely filled vessel and thus directly
from the collateral circulation. After deflation of the balloon, the catheter
was drawn back into the guiding catheter, where the same procedure (bal-
loon inflation, aspiration of blood) was repeated to obtain a control sample
from the systemic circulation. Blood was transferred into citrate tubes and
centrifuged at 1550g for 30 min. Plasma was taken off carefully, aliquoted,
snap frozen in liquid nitrogen and stored at –80C.
ELISA. A commercially available ELISA (Echelon Inc., Salt Lake City,
UT) was used for the detection of hyaluronic acid (HA) according to the
manufacturer’s instructions. Briefly, plasma samples were incubated with
HA binding protein and transferred to a detection plate for competitive
binding with pre-coated HA. An enzyme-linked antibody (alkaline phos-
phatase) detected the amount of HA binding protein on the plate, which
was inversely proportional to the concentration in the samples. Using 
p-nitrophenyl phosphate as a substrate, absorption was measured at 405 nm
using an EL808 spectrophotometer (BioTek, Winooski, VT). All ELISA
results were normalized for plasma albumin levels.
Animal experiments
This study conforms to the Guide for the Care and Use of Laboratory
Animals (NIH publication No. 85–23, revised 1996). After securing the
appropriate institutional approvals, 43 New Zealand White rabbits of com-
parable weight (3.0  0.2 kg) and age underwent unilateral ligation of 
the right femoral artery as previously described and sham operation of the
contralateral side under general anaesthesia with ketamine and xylazine
[6]. Forty animals received a single intra-arterial bolus infusion of 20 mg
filtered hyaluronidase (bovine testes, fraction IV-S, activity 750–1500 U/mg,
Sigma, St. Louis, MO) or heat-inactivated enzyme (90C for 15 min.) into
the proximal stump of the femoral artery (20 animals per group). The bolus
infusion was followed by implantation of an osmotic minipump (alzet,
durect corp., Cupertino, CA), connected to an infusion catheter. The tip of
the catheter was positioned distal to the branches of the arteria circumflexa
femoris and the arteria profunda femoris, pointing upstream in order to
deliver the substances (0.1 mg/hr active or inactive hyaluronidase) contin-
uously and during first-pass into the collateral circulation. Three animals
underwent femoral artery ligation only and served for the electron micro-
scopic studies of glycocalyx width.
Electron microscopic visualization of the endothelial glycocalyx.
Following induction of anaesthesia, the abdominal aorta was antegradely
cannulated caudal to the renal branches at day 1 following femoral artery
ligation for in situ perfusion staining of the endothelial glycocalyx as pre-
viously described for mice [7]. The protocol was adapted for the rabbit
species and because flow rate is critical for glycocalyx preservation, perfu-
sion was monitored continuously with an in-line flow probe installed in the
perfusion system (Transonic Systems, Ithaca, NY). Perfusion was started
with HEPES-buffered salt solution containing 0.1% BSA and 5 IU/ml
heparin at a controlled flow rate of 30 ml/min. The abdominal vena cava
was opened to create an outflow and perfusion was continued for 10 min.
to remove blood in the distal extremities. The animal was euthanized with
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an overdose of thiopental and perfusion was changed to a phosphate-
buffered fixative containing 15 mmol/l MgCl2 at 20 ml/min. for 2 min.
Finally, the hind limb was perfused with fixative solution containing 0.05%
alcian blue 8GX and 0.01% acridine orange (both Sigma) for 30 min. at 
20 ml/min. A detailed description of the staining solutions is published as
an on-line supplement by van den Berg et al. [7].
After perfusion, the vastus intermedius quadriceps muscle that con-
tains two distinct collateral arteries spanning from the circumflex femoral
artery to the arteria genualis was dissected and fixed overnight in 4%
paraformaldehyde. The following day, samples were post-fixed in 1%
osmium tetroxide and 1% lanthanum nitrate in water for 2 hrs at room
temperature, dehydrated in alcohol and embedded in epon. For orientation,
semi-thin sections were stained with toluidine blue. Thin sections (60 nm)
were stained in a saturated solution of uranyl acetate in 70% methanol fol-
lowed by Reynold’s lead citrate. The sections were examined using a
Technai 12 (FEI Co., Eindhoven, the Netherlands) equipped with a side-
mounted Megaview II camera (SIS, Muenster, Germany). Pictures were
analyzed using analySIS software 3.0 (Soft-Imaging, Muenster, Germany).
Width of the endothelial glycocalyx was measured at TEM magnifications
of 93,000	 and was defined as the distance of the stained structures
between the luminal membrane of the endothelial cell and their luminal
boundary as previously described [2].
Haemodynamic measurements of collateral conductance. Assessment
of the collateral conductance as the functional parameter of arteriogenesis
was performed in six animals per group as previously described at 7 days
following femoral artery ligation [6]. In short, a roller pump-driven shunt
was established between the carotid artery and the abdominal aorta, which
allowed perfusion of the hind limb vasculature at selected pressure levels.
Central-peripheral pressure differences between the abdominal aorta and
the saphenous arteries were recorded on a computerized system. Maximal
vasodilation was induced by adenosine infusion into the shunt system and
at each pressure level, differently labelled fluorescent microspheres were
injected into the shunt system. Following tissue harvest and processing,
the microspheres were quantified in a flow cytometer and collateral 
conductance was derived from the slope of the pressure-flow relation,
allowing a precise determination of the functional capacity of the develop-
ing collateral circulation.
Histological assessment of vascular proliferation and perivascular cell
infiltration. At 3 and 7 days following femoral artery occlusion, tissue sam-
ples from the quadriceps and adductor muscles were harvested from six
animals per group, snap frozen in liquid nitrogen and subsequently embed-
ded in tissue-tek (Sakura Finetek, Torrence, CA). Five micrometres frozen
sections were fixed in ice-cold acetone and incubated with a cross-reactive
mouse anti-rat antibody against Ki67 (Clone MIB-5, Dako, Glastrup,
Denmark). Macrophages were stained with a cross-reactive antibody
against CD68 (mouse anti-human, Clone EBM11, Dako).
A Cy3-labelled anti-mouse antibody (Amersham Biosciences, Uppsala,
Sweden) was used as a secondary reagent. Vascular smooth muscle cells
were visualized with a FITC-conjugated antibody against alpha-smooth
muscle actin (Sigma) and nuclei were stained with Hoechst 33342 dye
(Molecular Probes, Eugene, Oregon). Quantitative analyses of proliferation
indices and macrophage accumulation were performed in a blinded manner.
Quantitative RT-PCR. In animals per groups, the carotid artery was can-
nulated and the animals were exsanguinated at day 7 after femoral artery
ligation. The abdominal aorta was cannulated and the hind limb vascula-
ture was perfused with warm (37C) liquid latex (Chicago Latex Products
no. 563, Crystal Lake, IL) at a constant pressure of 80 mmHg to enable
visual identification and the gentle excision of collateral arteries. Collateral
arteries bypassing the site of femoral artery occlusion were carefully dis-
sected from the quadripecs and the adductor muscles after hardening of
the latex and snap frozen in liquid nitrogen. Total RNA was extracted from
the isolated arteries of the occluded and the unoccluded hind limb using
Tripure reagent (Roche, Basel, Switzerland) according to the manufac-
turer’s instructions, transcribed into cDNA and subjected to quantitative
reverse transcriptase polymerase chain reaction (RT-PCR), as described
before [8]. Primers used were TGF-1 (forward: 5-cttctccaccaactactgcttc-3;
reverse: 5-gtccaggctccagatgtagg-3), eNOS (forward: 5- agcctcactcc-
tgtcttcca-3; reverse: 5-gtggccttcactctctttgc-3), Ki67 (forward: 5-
caactttggtgattccatta-3; reverse: 5-ttaggaggcaagttttcatc-3), VCAM-1 (for-
ward: 5- gaacactcttacctgtgcacagc-3; reverse: 5-ccatcctcatagcaattaaggt-
gag-3), Integrin subunit 1 (forward: 5-gaatgtcaccaaccgtagc-3; reverse:
5-tcggaagtctgaagtcacc-3) and ABRA-1 (forward: 5-ttgccatagcatctctccttc -3;
reverse: 5-ggacatgtgcttcattatctgc -3),
All mRNA expression levels were normalized for 18s rRNA (forward:
5-tcaacacgggaaacctcac-3; reverse: 5-acaaatcgctccagcaac-3) and
expressed as a relative expression value.
Statistical analysis. Data are presented as mean  standard deviation.
Statistical analysis was performed with Prism 4 for Windows. A Wilcoxon
signed-rank test was used for the paired analysis of patient blood samples.
Since the RT-PCR results were not normally distributed, a Mann–Whitney
test was applied. A t-test was used for all other comparisons. P-values
0.05 were considered to be statistically significant.
Results
Patient study
Intracoronary blood samples were obtained from 40 patients with
stable coronary artery disease undergoing coronary angiography.
Patients with a non-total occlusion were grouped into collateral
responders (CFI 
 0.21, n  12) and non-responders (CFI 
0.21, n  12). Patient characteristics are listed in Table 1.
Measurements in blood samples obtained from the coronary
collateral circulation showed significantly higher hyaluronic acid
plasma levels compared with samples obtained from the systemic
circulation (Fig. 1). There was no significant correlation between
the individual increase in hyaluronic acid plasma levels and CFI
measurements. No differences between collateral-systemic gradi-
ents of hyaluronic acid were detected between non-responders,
responders and patients with a chronic total occlusion. Correlating
hyaluronic acid plasma levels and baseline characteristics, we
found that the ratio of collateral/systemic hyaluronic acid plasma
levels was significantly greater in patients with a family history 
of coronary artery disease (P  0.033) and with hypertension 
(P  0.035).
Animal study
Endothelial glycocalyx morphology is altered in proliferating 
collateral arteries. Attempting to follow up our findings from a 
heterogenous real-world patient population under experimental
conditions, we subjected New Zealand white rabbits to unilateral
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Non-responders (CFI 




CTOs (n  16) P-value
Age – years 62.8  13.5 61.4  11.0 61.9  11.8 0.95
Male sex – no. (%) 9 (75) 9 (75) 12 (58.3) 0.57
Body mass index (BMI) 27.2  2.6 27.0  2.8 26.4  4.9 0.82
Body surface area (BSA) 2.0  0.2 2.0  0.1 1.9  0.5 0.53
Hypertension – no. (%) 7 (58.3) 8 (66.7) 10 (62.5) 0.92
Hypercholesterolemia – no. (%) 5 (41.7) 7 (58.3) 5 (31.3) 0.36
Family history of CAD – no. (%) 10 (83.3) 7 (58.3) 8 (50.0) 0.19
Current smoker – no. (%) 4 (33.3) 1 (8.3) 3 (18.8) 0.42
Ex smoker – no. (%) 6 (50) 7 (58.3) 11 (68.8) 0.42
-blockers – no. (%) 11 (91.7) 9 (75.0) 15 (93.8) 0.29
Statins – no. (%) 10 (83.3) 11 (91.7) 16 (100) 0.25
Aspirin – no. (%) 11 (91.7) 11 (91.7) 16 (100) 0.50
Clopidogrel – no. (%) 6 (50) 11 (91.7) 11 (68.8) 0.08
Calcium antagonists – no. (%) 5 (41.7) 3 (25.0) 3 (18.8) 0.42
Nitrates – no. (%) 6 (50.0) 5 (41.7) 9 (56.3) 0.75
ACE-inhibitors/ARBs – no. (%) 4 (33.3) 4 (33.3) 8 (50) 0.57
C-reactive protein – mg/dl 1.75 [0.7; 6.3] 1.4 [0.8; 3.5] 1.5 [1.0;3.3] 0.75
Haemoglobin – mmol/l 8.63  0.61 8.71  0.41 8.83  0.70 0.68
Glucose – mmol/l 6.0  1.1 6.0  2.1 5.9  0.8 0.97
Total cholesterol – mmol/l 4.0  0.9 3.8  0.8 3.8  0.8 0.77
LDL-cholesterol – mmol/l 1.2  0.4 1.1  0.2 1.3  0.3 0.32
HDL-cholesterol – mmol/l 2.1  0.7 2.0  0.8 2.0  0.7 0.85
Table 1 Patient characteristics
Fig. 1 Schematic drawing of experi-
mental set-up of collateral flow index
measurements and blood sample
aspiration during coronary angiogra-
phy in coronary artery disease
patients (A). Blood samples aspirated
via the collateral network contained
significantly higher levels of
hyaluronic acid than samples from
the proximal site (B).
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femoral artery. At different time-points after induction of collateral
artery growth, we directly visualized the endothelial surface glyco-
calyx by employing a protocol of combined in situ staining with
alcian blue and acridine orange and subsequent electron
microscopy. We found a significant thinning of the glycocalyx
width in recruited collateral arteries compared with quiescent
anastomoses (Fig. 2). At 24 hrs following femoral artery ligation,
the width of the endothelial surface coat was on average 67.5 
47.2 nm in the newly recruited collateral arteries, whereas the gly-
cocalyx in the corresponding non-recruited anastomoses from the
sham-operated contra-lateral hind limb was significantly thicker
(P  0.001) with an average width of 101.0  11.3 nm. In addi-
tion, the glycocalyx in growing collateral arteries showed an undu-
lating luminal surface and a more heterogeneous distribution on
the endothelial cell membrane.
Because a decrease in glycocalyx width has previously shown
to correlate with an increase in infiltration of monocytes to in
developing atherosclerotic lesions, we quantified the number of
perivascular macrophages around collateral arteries and quiescent
anastomoes. Staining of frozen sections from the quadriceps
muscle verified the accumulation of CD68 positive cells in the
perivascular space of growing collateral arteries, whereas only few
cells were present around the arteries from the unoccluded hind
limb (CD68 cells/mm2: Collateral arteries: 26.5  7.0, quiescent
anastomoses: 1.6  2.3).
Additional glycocalyx perturbation by hyaluronidase infusion
stimulated perivascular monocyte infiltration, but significantly
attenuated collateral artery growth. Because a partial shedding of
endothelial glycocalyx in growing collateral arteries was correlated
with an increased perivascular monocyte infiltration around collateral
© 2009 The Authors
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Fig. 2 Electron microscopic imaging
of Alcian blue 8GX stained rabbit
arteries from the quadriceps muscle
at 39,000	 (A, B) and 93,000	
magnification (C, D). The glycocalyx
on the luminar surface as well as in
the endothelial cell caveolae stains
dark and is reduced in growing col-
lateral arteries (B, D) compared with
quiescent anastomoses from the
unoccluded hind limb (A, C).
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arteries and the glycocalyx has previously been shown to directly
modulate leucocyte adhesion and infiltration [9], we hypothesized
that an additional perturbation of the endothelial surface coating
could result in a further enhancement of monocyte infiltration and
a stimulation of collateral artery growth. We therefore infused the
enzyme hyaluronidase locally into the stem vessels of the collat-
eral circulation to induce a continuous deduction of hyaluronic
acid from the glycocalyx and thereby a further perturbation of the
endothelial surface coating. The effects of hyaluronidase infusion
were visualized in electron microscopy and infusion of the heat-
inactivated enzyme served as a control. Indeed, a single intra-
arterial bolus infusion of 20 mg hyaluronidase 1 hr before begin of
the in situ staining procedure reduced average glycocalyx width
on the collateral artery surface to 17.5  6.0 nm, whereas infu-
sion of the inactive enzyme did not visibly affect the endothelial
coat (width 58.7  41.1 nm, P  0.001 for hyaluronidase versus
inactive enyzme) (Fig. 3).
To asses a potential stimulating effect of glycocalyx degrada-
tion on monocyte infiltration, we performed histological analyses
of the perivascular macrophage accumulation at 3 and 7 days fol-
lowing femoral artery ligation (Fig. 4).
Glycocalyx perturbation resulted in a significantly higher num-
ber of perivascular CD68 macrophages at day 3, compared with
control animals treated with heat-inactivated hyaluronidase
(CD68 cells/mm2: hyaluronidase: 18.9  4.1; controls: 7.3 
2.9). At 7 days, the perivascular macrophage accumulation had
further increased in both groups and no significant difference was
detectable any more (CD68 cells/mm2: hyaluronidase: 27.6 
16.5; Controls: 26.5  7.0).
Because the number of perivascular macrophages at day 3
after femoral artery ligation has been shown to correlate with the
restoration of hindlimb perfusion [10], we measured the conduc-
tance (collateral flow/gradient of perfusion pressure) of the devel-
oping collateral circulation using fluorescent microspheres.
However, despite the increase in perivascular macrophages
achieved by this treatment, the continuous infusion of
hyaluronidase into the stem vessels of the collateral circulation
resulted not in a stimulation but in a significant impairment of
arteriogenesis following femoral artery ligation (ml/min./100
mmHg: hyaluronidase: 27.5  3.5; Controls: 47.1  3.83; P 
0.001). This attenuation of collateral artery growth was also
reflected on a cellular level, where histological staining for actively
proliferating vascular smooth muscle and endothelial cells
revealed a significantly lower number of Ki67 smooth muscle
cells in the hyaluronidase treated group (%Ki67VSMC:
hyaluronidase: 15.3  2.07; Controls: 19.1  1.28; P  0.018)
(Fig. 5). This increased number of Ki67 cells was also reflected
by a lower expression of Ki67-mRNA in qRT-PCR analysis of iso-
lated collateral arteries following glycocalyx perturbation (Ki67
mRNA [relative expression]: hyaluronidase: 0.21  0.29;
Controls: 1.0  0.99; P  0.027).
Hyaluronidase has no direct anti-proliferative effect on vascular
smooth muscle cells. To investigate a potential direct inhibitory
effect of hyaluronidase on vascular smooth muscle cell prolifera-
tion, we added different concentrations of hyaluronidase to cultured
VSMCs. Incubation with hyaluronidase in vitro did not influence
smooth muscle cell proliferation (see supplementary data section).
Perturbation of the glycocalyx reduced the expression of
shear-regulated and pro-arteriogenic genes in collateral arteries.
As the endothelial glycocalyx was previously shown not only to
influence leucocyte adhesion but also to facilitate mechanotrans-
duction of fluid shear stress in endothelial cells, we measured the
expression of eNOS and TGF-1 as two shear stress–regulated
genes involved in arteriogenesis. Quantitative RT-PCR of isolated
collateral arteries showed a small but significant reduction in
expression of both eNOS (relative expression: hyaluronidase: 
0.31  0.57; Controls: 1.0  1.43; P 0.039) and TGF-1 (relative
expression: hyaluronidase: 0.41  0.32; Controls: 1.0  0.65; 
P  0.033) in animals that underwent continuous hyaluronidase
infusion compared with control animals. There were no significant
differences in the expression of integrin 1 (relative expression:
hyaluronidase: 0.64  1.40; Controls: 1.0  1.99; P  0.68),
VCAM-1 (relative expression: hyaluronidase: 1.06  1.43;
Controls: 1.0  2.79; P  0.97) or the recently described 
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Fig. 3 Quantification of glycocalyx thickness in collateral arteries and quiescent anastomoses. Infusion of inactivated hyaluronidase had not significant
effect on the glycocalyx width (B), whereas the active enzyme almost completely removed the endothelial surface layer (A).
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pro-arteriogenic transcription factor ABRA-1 (relative expression:
hyaluronidase: 2.07  7.03; Controls: 1.0  2.22; P  0.58).
Discussion
We provide indirect evidence for the local shedding of hyaluronic
acid from the endothelial glycocalix in the coronary collateral cir-
culation of coronary artery disease patients and describe a
reduced endothelial glycocalyx width and altered glycocalyx sur-
face pattern in growing collateral arteries following femoral artery
occlusion in the rabbit. This decrease in glycocalyx width is corre-
lated with the accumulation of perivascular macrophages around
growing collateral arteries and further glycocalyx degradation by
continuous local hyaluronidase infusion resulted in a temporary
stimulation of monocyte infiltration. However, this approach of
glycocalyx perturbation resulted not in a further stimulation, but in
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Fig. 4 Macrophage accumulation around growing collateral arteries from the quadriceps muscle (400	 magnification) shown in a double staining for the
macrophage marker CD68 (red) and alpha-smooth muscle actin (green). Macrophages were not regularly present in the perivascular space of unrecruited
anastomoses (A, B). Following femoral artery ligation, macrophages are accumulating around growing collateral arteries at day 3 after the induction of
arteriogenesis, with a significantly higher number of infiltrating cells in animals treated with hyaluronidase (C), compared to animals treated with the inac-
tivated enzyme (D). At day 7, this difference between hyaluronidase treated (E) and control animals (F) was no longer statistically significant (G).
Glycocalyx perturbation resulted in a significant reduction of the expression of the shear stress–regulated pro-arteriogenic genes eNOS and TGF-1 (H).
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a strong attenuation of collateral artery growth. This might be due
to a negative effect on endothelial shear stress sensing and
mechanotransduction, as suggested by the decreased expression
of shear stress–regulated pro-arteriogenic genes in collateral
arteries following artificial glycocalyx perturbation. This is the first
study implicating an involvement of the endothelial glycocalyx in
collateral artery growth.
Arteriogenesis and angiogenesis
The growth of functional collateral arteries (arteriogenesis) differs
in several aspects from the sprouting process of capillaries
(angiogenesis). The term arteriogenesis refers to the enlargement
of pre-existing arterial and arteriolar blood vessels upon the occlu-
sion or stenosis of a major artery in the same perfusion territory
[11]. Although hypoxia is the main stimulus for angiogenesis,
arteriogenesis is relatively independent of local oxygen tension
and driven by a change of biomechanical forces due to the
increase in the pre- and post-stenotic pressure gradient, resulting
in a shift of blood flow towards the yet unrecruited anastomoses.
Meanwhile there is compelling evidence that fluid shear stress is
indeed an important stimulus for arterial enlargement [12].
Although angiogenesis and arteriogenesis differ in these aspects,
they also share several mechanistic principles, such as the infiltra-
tion of circulating cells. The different forms of vascular growth
have recently been reviewed [13].
Endothelial glycocalyx morphology in growing
collateral arteries
Besides heparan sulphate proteoglycans, hyaluronic acid gly-
cosaminoglycans are a main component of the glycocalyx [14].
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Fig. 5 (A) Haemodynamic assess-
ment of collateral conductance.
Microsphere-based perfusion meas-
urements demonstrated a significant
reduction in the conductance of col-
lateral arteries at 7 days following
femoral artery ligation in the
hyaluronidase-treated group com-
pared with the control animals. (B)
Proliferation of vascular smooth
muscle cells in collateral arteries
(400	 magnification). Using a dou-
ble staining for the proliferation
marker Ki67 (red) and alpha-smooth
muscle actin (green), the percentage
of Ki67-positive nuclei of all nuclei
(blue) of vascular smooth muscle
cells was calculated. Hyaluronidase
infusion resulted in a significantly
lower number of actively proliferating
cells (C) in collateral arteries com-
pared with control animals treated
with inactive enzyme (D). Unrecruited
anastomoses from the unoccluded
hind limb show almost no smooth
muscle cell proliferation in both the
hyaluronidase (E) and the control
group (F).
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Arterial as well as capillary and venous endothelial cells have been
shown to be covered with this endothelial surface layer and
dimensions of the glycocalyx have previously been shown to dif-
fer locally within the arterial tree: The disturbed flow pattern in the
carotid bifurcation is correlated with a reduced glycocalyx width,
potentially contributing to leucocyte adhesion and atherosclerotic
lesion development [2]. In our study, we now observe a similar
phenomenon in newly recruited collateral arteries, with a reduced
glycocalyx width and a more irregular surface pattern compared
with quiescent anastomoses. Both ischaemia as well as pro-
inflammatory stimuli [15] have previously been shown to induce a
shedding of the endothelial glycocalyx, decreasing the glycocalyx
barrier for leucocyte adhesion and extravasation [16]. In the case
of arteriogenesis, infiltration of circulating cells in the perivascular
space is essential to mediate the remodelling process resulting in
the increase in arterial diameter [4, 17]. Arteriogenesis is an
inflammatory-like process [16] and the adaptive reduction of local
glycocalyx width could facilitate the adhesion of circulating leuco-
cytes to the collateral endothelium and subsequent transmigration
in the perivascular space. Indeed, our results show an increased
number of perivascular macrophages around growing collateral
arteries compared with the quiescent anastomoses from the con-
tralateral hind limb, in good correspondence with previous studies
in different animal models of arteriogenesis [18, 19]. In addition,
further glycocalyx perturbation resulted in an increase in the num-
ber of perivascular macrophages at 3 days after femoral artery lig-
ation. In vitro data also suggest a change in glycocalyx composi-
tion dependent on fluid shear stress pattern with a stimulation of
hyaluronan incorporation by high laminar shear stress [20]. Since
our merely morphological assessment of the collateral glycocalyx
did not allow an analysis of glycocalyx composition, this question
remains to be answered by future investigations.
Effects of glycocalyx perturbation on collateral
artery growth
Following this description of altered glycocalyx dimensions in
growing collateral arteries, we wanted to investigate the functional
importance of the endothelial surface layer for adaptive arteriogen-
esis and studied collateral artery growth under conditions of a per-
turbed glycocalyx following hyaluronidase infusion. The systemic
infusion of this degrading enzyme has been shown to significantly
reduce glycocalyx width on the capillary endothelium in rats [7]
and hamsters [21]. Our electron microscopical studies on rabbit
collateral arteries verified this effect of hyaluronidase infusion and
showed a severely reduced endothelial surface layer with electron
microscopical images comparable to those of previous studies [7].
Interestingly, this perturbation of the endothelial glycocalyx
resulted in a significant attenuation of collateral artery growth
compared with the control group receiving inactivated enzyme.
Although natural arteriogenesis is correlated with the spontaneous
reduction of mean glycocalyx width in growing collateral arteries,
the further derogation had an inhibitory effect. The number of
perivascular macrophages as pro-arteriogenic mediators was
higher in the hyaluronidase-treated group, making the effects on
leucocyte adhesion an unlikely explanation for this observation.
However, besides modulating endothelial–leucocyte interactions,
the endothelial glycocalyx has previously been shown to be an
important mediator of shear stress sensing and of flow-mediated
vascular reactions [22]. Both heparan sulphate proteoglycans and
hyaluronidic acid glycosaminoglycans are involved in endothelial
cell mechanotransduction: Pre-treatment of bovine aortic
endothelial cells with heparinidase III for 2 hrs completely inhib-
ited the induction of NO in response to steady and oscillatory
shear stress [23]. In isolated canine femoral arteries,
hyaluronidase treatment reduced flow induced NO production by
80% [24]. Acetylcholine-induced production of NO remained unaf-
fected by glycocalyx perturbation, indicating that hyaluronic acid
is essential for shear-stimulated but not for agonist induced NO-
production. Because arteriogenesis is largely driven by increased
fluid shear stress following collateral artery recruitment [12],
impairment in endothelial shear stress sensing could explain the
observed attenuation of arteriogenesis following glycocalyx per-
turbation. The shear stress–regulated genes eNOS and TGF-1
have previously been shown to be up-regulated in growing collat-
eral arteries and to be functionally important for the arteriogenic
response following femoral artery occlusion [25–27]. Using quan-
titative RT-PCR, we now found a significantly reduced expression
of both eNOS and TGF-1 in collateral arteries from
hyaluronidase-treated animals. Because fluid shear stress and the
changes in collateral gene expression induced by this mechanic
stimulus are an important driving force of arteriogenesis [3], these
findings could explain the attenuated collateral artery growth fol-
lowing glycocalyx perturbation. A recent study in the hamster win-
dow chamber model also described an impaired capillary perfu-
sion following acute hyaluronidase infusion [28]. In our own
model, continuous infusion of high-dose adenosine into the per-
fusion system ensures maximal vasodilation at the time of haemo-
dynamic measurements and excludes potential differences in
vasomotor tonus as a confounding factor. Hyaluronidase effects
on endothelial shear stress sensing could, however, be a common
explanatory mechanism for both flow-dependent vascular relax-
ation and shear stress–mediated collateral artery growth.
CFI measurements and glycocalyx shedding
The invasive assessment of CFI using intracoronary pressure
measurements is currently considered the most accurate and sen-
sitive method of evaluating collateral circulation in patients [29]
and recent investigations have tried to link circulating cellular
markers to different degrees of collateralization [5, 30]. Therefore,
one might expect that the degree of glycocalyx shedding in indi-
vidual patients positively correlates with their CFI measurements.
However, this was not the case in the present study. CFI in patients
is often assessed irrespective of the phase in time of collateral
artery development, that is, it mostly remains unknown in patients
how long coronary collateral arteries have been growing, or if
growth has already come to a halt. Time course of collateral artery
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growth may strongly influence glycocalyx shedding, which might
occur to large extent in rapidly growing arteries (such as in our
animal model after acute occlusion) and diminish in a more stable
plateau phase of collateralization. Also, intracoronary measure-
ments of hyaluronic acid might not be sensitive enough to pick up
small differences between different degrees of collateralization.
Another important issue is in how far the intracoronary blood
samples truly represent the collateral-derived blood only. In all
patients, the first 3 ml of blood withdrawn were discarded, so that
inaccuracies due to other fluids still in the catheter are avoided.
Furthermore, equilibrium of collateral perfusion will have built up,
which is also indicated by stable values of pressure-derived CFI
after the first minute of balloon occlusion of the original artery. In
patients with chronic total occlusion, blood distal to the occlusion
is dependent on collateral flow only, so that the equilibrium has
already been formed.
Stroes and co-workers recently employed an interesting tech-
nique of measuring intravascular distribution volumes as an indi-
rect but sensitive marker of glycocalyx volumes in patients [31].
However, this technique primarily measures capillary glycocalyx
volume rather than glycocalyx volumes of larger vessels such as
collateral arteries and was therefore not suitable for our study.
Clinical implications
While representing an important structural component of all
blood vessels in the human body, the endothelial glycocalyx has
been little explored regarding its role in vascular pathology and
adaptation. Only in the last few years, increasing evidence indi-
cated a crucial role of the endothelial glycocalyx in atherosclerotic
plaque formation, ischaemia/reperfusion injury [7] and diabetic
vasculopathy [32]. In type 1 diabetic patients, total endovascular
glycocalyx volume was reduced to about 50% of healthy volun-
teers [33], and in an atherosclerotic mouse model reduced glyco-
calyx dimensions precede the development of atherosclerotic
lesions [2]. Interestingly, both diabetes [34] as well as hypercho-
lesterolemia [35] are also correlated with a severe impairment of
collateral artery growth. Although several explanations have been
postulated [36], the mechanisms for this negative effect remain
largely unknown. Our study now directly demonstrates a func-
tional relevance of glycocalyx integrity for arteriogenesis and
warrants further investigations whether glycocalyx perturbation
may be a causal factor for impaired collateral artery growth in the
clinical setting.
Study limitations
Our electron microscopical studies verified a significantly reduced
glycocalyx dimension and displayed a decreased expression of
shear stress–regulated pro-arteriogenic genes in collateral arter-
ies. However, our loss of function approach does not definitely
exclude other effects of hyaluronidase infusion that might nega-
tively affect arteriogenesis independent of glycocalyx perturbation.
However, a direct inhibitory effect of hyaluronidase on cultured
vascular smooth muscle cell proliferation was not detected.
Because the endothelial glycocalyx is quickly regenerated after
discontinuation of the hyaluronidase infusion, no rescue experi-
ment by therapeutic glycocalyx reconstitution could be performed
in our model.
Conclusion
These results implicate the endothelial glycocalyx as a novel
player in the regulation of adaptive arteriogenesis and the expres-
sion of shear-stress regulated pro-arteriogenic genes in collateral
arteries. However, the direct link between glycocalyx perturbation
and endothelial shear stress sensing in collateral artery growth yet
remains to be made. As one of the basic structural elements of the
vascular wall, the function of this endothelial surface lining is not
limited to mechanotransduction. Besides the modulation of leuco-
cyte adhesion and pro-arteriogenic gene expression investigated
in our study, the binding and presentation of growth factors and
cytokines on the endothelial surface could be an additional mech-
anistic factor in this context. The modulatory function of
hyaluronic acid on inflammation and proliferation has recently
been reviewed by our group [37].
The endothelial surface represents a new target for the ther-
apeutic stimulation of collateral artery growth. Further studies
in disease models with a morbidity-induced glycocalyx pertur-
bation (e.g. diabetic animals) are warranted to determine the
potential effects of glycocalyx reconstitution on collateral
artery growth.
Supporting Information
Supplementary data 1: In vitro vascular smooth
muscle cell proliferation assay
Methods: Vascular smooth muscle cells were culture in standard
medium in the presence of 10% foetal bovine serum (FBS), and
hyaluronidase (0, 1, 10, 100 g/ml) was added to the culture for
24 hrs. Proliferation was measured using an assay based on BrdU
incorporation (Roche, Mannheim, Germany) according to the
manufacturer’s instructions. In short, 10 M BrdU was added to
each vial for 4 hrs. After fixation and permeabilization, anti-BrdU
antibody linked to peroxidase was added and cells were incubated
for 90 min. Following the necessary washing steps, substrate
solution to visualize the bound peroxidase was added and absorp-
tion was measured at 450 nm in an EL808 spectrophotometer
(BioTek, Winooski, VT).
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Results: Hyaluronidase has no direct anti-proliferative effect on
vascular smooth muscle cells.
To investigate a potential direct inhibitory effect of hyaluronidase
on vascular smooth muscle cell proliferation, we added different
concentrations of hyaluronidase to cultured VSMCs. Incubation
with hyaluronidase in vitro did not influence smooth muscle cell
proliferation (BrdU incorporation [absorption units]: 0g/ml
hyaluronidase: 0.85  0.12; 1 g/ml: 0.85  0.09; 10 g/ml: 0.79
 0.11; 100 g/ml: 0.84  0.18).
This material is available as part of the online article from:
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1582-
4934.2009.00735.x
(This link will take you to the article abstract).
Please note: Wiley-Blackwell are not responsible for the content or
functionality of any supporting materials supplied by the authors.
Any queries (other than missing material) should be directed to
the corresponding author for the article.
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